Elliot Norry

Companies

• Adaptimmune (United Kingdom)Chief Medical Officer Jan 13, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AUAdaptimmune (United Kingdom) ADAPY7,510 shares²$176 at $0.02Jan 17, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 17, 2025Sold 5,584 shares at $0.58 of Adaptimmune (United Kingdom)²
• Jan 15, 2025Sold 9,803 shares at $0.57 of Adaptimmune (United Kingdom)³
• Jan 13, 2025Sold 8,124 shares at $0.59 of Adaptimmune (United Kingdom)³
• Jan 13, 2025Sold 4,268 shares at $0.59 of Adaptimmune (United Kingdom)³
• Jan 17, 2024Sold 12,967 shares at $0.67 of Adaptimmune (United Kingdom)⁴
• Jan 17, 2024Sold 5,309 shares at $0.67 of Adaptimmune (United Kingdom)⁴
• Jan 16, 2024Sold 2,287 shares at $0.79 of Adaptimmune (United Kingdom)⁴
• Jan 12, 2024Sold 7,799 shares at $0.85 of Adaptimmune (United Kingdom)⁵
• Jan 11, 2024Sold 4,009 shares at $0.84 of Adaptimmune (United Kingdom)⁵
• Jan 17, 2023Sold 2,159 shares at $1.86 of Adaptimmune (United Kingdom)⁶
• Jan 12, 2023Sold 7,449 shares at $1.71 of Adaptimmune (United Kingdom)⁷
• Jan 11, 2023Sold 3,843 shares at $1.75 of Adaptimmune (United Kingdom)⁷
• Jan 4, 2023Sold 876 shares at $1.69 of Adaptimmune (United Kingdom)⁸
• Jan 18, 2022Sold 2,121 shares at $3.19 of Adaptimmune (United Kingdom)⁹
• Jan 12, 2022Sold 854 shares at $3.54 of Adaptimmune (United Kingdom)¹⁰
• Jan 11, 2022Sold 3,770 shares at $3.56 of Adaptimmune (United Kingdom)¹⁰
• Jan 4, 2022Sold 849 shares at $4.06 of Adaptimmune (United Kingdom)¹¹